Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr ...
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Atara Biotherapeutics, Inc.’s ATRA share price has surged by 12.53%, which has investors questioning if this is right time to ...
Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or the "Company") . Such investors are advised to contact Danielle Peyton at ...
As night fell across a remote region of northern Australia, a “velvet” creature emerged from a pile of rocks. Its hard-to-reach habitat and camouflaged coloring helped it go largely unnoticed — until ...
The testbed for the latest and greatest radar under development for the Eurofighter Typhoon is an unusual looking model of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results